Friday, December 5, 2025
Search

Masimo Corporation And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Via News Editorial Team

December 16, 2022

Masimo Corporation  And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) - Masimo Corporation (MASI), Halliburton Company (HAL), CrossFirst Bankshares (CFB) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Masimo Corporation (MASI)

88.4% sales growth and 14.71% return on equity

Masimo Corporation designs, produces, and sells noninvasive monitoring technology and solutions for hospital automation worldwide. Masimo Signal Extract Technology (SET) pulseoximetry is offered by the company. It offers measure-through motion pulse oximetry and low pulse oximetry monitoring. This addresses some of the limitations inherent in conventional pulse oximetry. Masimo Rainbow SET Platform also offers non-invasive monitoring of hemoglobin, such as oxygen saturation, pulse rate and perfusion index. It calculates the oxygen content and reserves index. SedLine brain function technology is offered by the company. It measures brain activity using EEG signals. Capnography products include gas monitors and external gas analyzers. Integrated modules and handheld capsnographs and capnometers. There are also capnography sampling lines. O3 regional oxygenmetry can be used to determine tissue oxygen saturation. Masimo Hospital Automation Platform includes Patient SafetyNet and surveillance; Kite; UniView, Replica; UniView: 60; and MyView. It offers coronavirus 2019 response, telehealth solutions and connectivity devices. The company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, physician offices, long term care facilities, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. The company was founded in Irvine, California in 1989.

Earnings per Share

Masimo Corporation's trailing 12 months profit per share is $3.94

PE Ratio

Masimo Corporation's trailing 12-month price-earnings ratio is 36.62. The purchaser of the shares is therefore investing $36.62 per dollar in annual earnings.

For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 14.71%.

Annual Top and Bottom Value

Masimo Corporation stock was valued at $144.31 as of 10:22 EST. This is way lower than the 52-week high at $299.78, and much higher than its 52 week low at $108.89.

Volume

The Masimo Corporation's latest reported volume is now 686252, which is 2.3% more than its average volume (670170).

Sales Growth

Masimo Corporation's sales growth is 73.5% for the present quarter and 88.4% for the next.

Growth Estimates Quarters

For the current quarter, the company expects to grow by 2.1% for the next quarter and 3.3% the following.

2. Halliburton Company (HAL)

31.9% sales growth and 26.35% return on equity

Halliburton Company provides products and services to the energy industry worldwide. It operates in two segments, Completion and Production, and Drilling and Evaluation. The Completion and Production segment offers production enhancement services that include stimulation and sand control services; cementing services, such as well bonding and casing, and casing equipment; completion tools that offer downhole solutions and services, including well completion products and services, intelligent well completions, and service tools, as well as liner hanger, sand control, and multilateral systems; production solutions comprising coiled tubing, hydraulic workover units, downhole tools, and pumping and nitrogen services; and pipeline and process services, such as pre-commissioning, commissioning, maintenance, and decommissioning. This segment also provides electrical submersible pumps, as well as artificial lift services. The Drilling and Evaluation segment offers drilling fluid systems, performance additives, completion fluids, solids control, specialized testing equipment, and waste management services; oilfield completion, production, and downstream water and process treatment chemicals and services; drilling systems and services; wireline and perforating services consists of open-hole logging, and cased-hole and slickline; and drill bits and services comprising roller cone rock bits, fixed cutter bits, hole enlargement, and related downhole tools and services, as well as coring equipment and services. This segment also provides cloud based digital services and artificial intelligence solutions on an open architecture for subsurface insights, integrated well construction, and reservoir and production management; testing and subsea services, such as acquisition and analysis of reservoir information and optimization solutions; and project management and integrated asset management services. Halliburton Company was founded in 1919 and is based in Houston, Texas.

Earnings per Share

Halliburton Company's trailing twelve-month EPS is $-1.99.

For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 26.35%.

Annual Top and Bottom Value

Halliburton Company stock was valued at $35.76 as of 10:22 EST. This is way lower than the 52-week high at $43.99, and much higher than the 52-week low at $21.07.

Growth Estimates Quarters

The company's growth estimates for the ongoing quarter and the next is 80.6% and 80%, respectively.

Moving Average

Halliburton Company is worth more than its moving average for 50 days of $34.59, and higher than its moving average for 200 days of $33.73.

3. CrossFirst Bankshares (CFB)

26.7% sales growth and 11.43% return on equity

Earnings Per Share

As for profitability, CrossFirst Bankshares has a trailing twelve months EPS of $1.08.

PE Ratio

CrossFirst Bankshares has a trailing twelve months price to earnings ratio of 12.58. Meaning, the purchaser of the share is investing $12.58 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.43%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 1.1%, now sitting on 198.84M for the twelve trailing months.

Sales Growth

CrossFirst Bankshares's sales growth is 15.5% for the current quarter and 26.7% for the next.

Growth Estimates Quarters

The company's growth estimates for the current quarter is a negative 20% and positive 6.1% for the next.

4. Novanta (NOVT)

9% sales growth and 12.42% return on equity

Novanta Inc. and its subsidiaries design, manufacture, market, and sell photonics and vision components to original equipment makers in the industrial and medical markets around the world. The company's Photonics division offers photonics solutions including beam delivery and laser scanning, laser scanning, laser marking, laser solid state, lasers, lasers with high speed, lasers that can be used for laser-based industrial processes, as well as products to power optical light engines. These include medical, life-science imaging, laser sequencing and metrology. Vision provides medical-grade technologies such as medical insufflators and pumps and associated disposables. It also offers wireless recorders and video integration technology for operating room integrations. The Precision Motion segment includes optical and inductive encoders as well as precision motors and motion control sub-assemblies. It also offers servo drives and air bearings. It sells products via its direct sales force as well as through resellers and distributors. The original name of the company was GSI Group, Inc., but it changed its name in May 2016 to Novanta Inc. Novanta Inc. was established in 1968. It is located in Bedford, Massachusetts.

Earnings per Share

Novanta's trailing twelve-month EPS is $1.25.

PE Ratio

Novanta's trailing 12-month price-earnings ratio is 127.43. The purchaser of the shares is therefore investing $127.43 per dollar in annual earnings.

For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 12.42%.